Key Account Manager Hematology & Oncology
Incyte
Key Account Manager Hematology & Oncology
Incyte
Biopharmaceutical company pursuing drug discovery.
This is a contractor position supporting Incyte, with the contract held through a third-party partner.
Build connections. Shape opportunities. Help move care forward.
Behind every treatment decision is a network of people, conversations and connections. A physician seeking answers. A care team navigating a complex pathway. A patient waiting for what comes next.
Understanding how these pieces connect takes curiosity. Earning the trust to contribute takes commitment. Turning that understanding into meaningful action takes someone ready to build.
At Incyte, we are looking for a Key Account Manager to help shape the next chapter of our Hematology and Oncology business in West Switzerland. Someone hungry to learn, confident enough to ask thoughtful questions and determined enough to turn insight into progress.
You will take ownership of your territory, build trusted relationships with healthcare professionals and bring colleagues together around opportunities that matter. Your impact will come from understanding where science, customer needs and business priorities meet—and knowing how to move things forward.
The impact you can have
Build a territory with purpose.
Translate our Swiss strategy into a focused territory plan. Identify the accounts and opportunities where you can make the greatest contribution, set clear priorities and take ownership of sustainable commercial growth.
Understand the people behind the account.
Explore how treatment decisions are made, how patients move through care and where healthcare professionals encounter barriers. Build relationships through listening, scientific curiosity and conversations that bring value.
Turn insight into action.
Look beyond the first answer. Uncover underlying needs, connect market and customer insights, and translate them into clear account plans, relevant engagements and measurable business opportunities.
Bring the right people together.
Work closely with Medical, Market Access, Marketing and other colleagues to address account needs. Share what you learn, align around priorities and follow through on commitments, respecting each function’s responsibilities.
Create opportunities for meaningful exchange.
Identify and deliver projects that respond to local needs, including HCP roundtables, educational meetings and sponsorship initiatives, in line with national strategy and applicable requirements.
Make progress visible.
Use territory data, customer insights and relevant KPIs to assess what is working and adapt your approach. Combine customer engagement and multichannel execution with clear account planning and disciplined CRM documentation.
What you bring
You combine the ambition to grow a business with the curiosity to understand a complex scientific environment. You enjoy building relationships over time, take initiative when you see an opportunity and stay resourceful when progress requires a different approach.
We would like to meet you if you bring:
Experience in sales and territory management is an advantage, particularly within the Swiss pharmaceutical industry. Experience in Hematology or Oncology is especially valuable.
What you will help build
This role offers the opportunity to shape how we engage across a diverse territory, develop lasting partnerships and contribute directly to the growth of Incyte’s Hematology and Oncology portfolio in Switzerland.
You will report to the Commercial Lead Hematology / Oncology, Switzerland, and cover Geneva, Jura, Vaud, Valais, Fribourg, Bern, Solothurn and Ticino.
Incyte develops and sells medicines by discovering and developing new drugs, focusing on diseases in inflammation, autoimmunity, and blood cancers. Its core product, Jakafi (ruxolitinib), is a JAK1/2 inhibitor approved to treat a rare blood cancer and works by blocking JAK enzymes to reduce abnormal blood cell growth. The company also expands its pipeline through research collaborations, partnerships, and acquisitions, such as the 2024 purchase of Escient Pharmaceuticals to strengthen its inflammation and autoimmune portfolio. Unlike some competitors that rely mainly on internal programs, Incyte combines in-house discovery with external collaborations and strategic deals to grow its drug candidates from early research to approved therapies. The goal is to deliver medicines that help patients with serious diseases by building a diverse, clinically validated portfolio of treatments through internal efforts and partnerships.
Explore more opportunities at Incyte